CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
종목 코드 CBLL
회사 이름Ceribell Inc
상장일Oct 11, 2024
CEOChao (Xingjuan)
직원 수281
유형Ordinary Share
회계 연도 종료Oct 11
주소360 N. Pastoria Avenue
도시SUNNYVALE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94085
전화18004360826
웹사이트https://ceribell.com/
종목 코드 CBLL
상장일Oct 11, 2024
CEOChao (Xingjuan)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음